Smokers have significantly worse health and die younger than the rest of us, with much of this thought to be due to inflammation and other immune system effects. Researchers here look at some of the proteins for which altered levels are already known to be associated with aging and longevity in humans and mice, in particular FGF-21, finding differences between smokers and non-smokers:
The average life span of smokers is more than 10 years shorter than that of non-smokers, and it is said that smoking is a factor which accelerates aging. However, the details of the mechanism which accelerates aging due to smoking was not yet clear. A research group found that smoking habits affected the aging-related molecule α-klotho (αKl) in blood serum. In addition, this group also elucidated that smoking causes a rise in blood serum concentration of fibroblast growth factor (FGF)-21, a factor related to metabolism which has gained attention in recent years.
The group focused on the relationship between smoking and aging, examining the involvement of Klotho in the advancement of aging due to smoking. It was found that the levels of FGF-21 related to metabolism, α-Klotho, and interleukin(IL)-6, a cytokine related to inflammation, were significantly higher in smokers than in never-smokers. In addition, the blood serum concentration of α-Klotho rose in stressful conditions such as lack and sleep and being under emotional stress outside of smoking. FGF-21 is negatively-correlated to adiponectin, which is known as a cytokine related to metabolism, and the rise in FGF-21 in smokers is thought to suggest a metabolic disorder.
By contrast, it was shown that in never-smokers, α-Klotho has a positive correlation with IL-6, but this correlation was not found in smokers. Past reports have stated that α-Klotho holds anti-inflammatory effects, so it is thought that the lack of this correlation between α-Klotho and IL-6 in smokers is possible due to the weakening of anti-inflammatory effects of α-Klotho brought about by smoking stress.